CNBX Pharmaceuticals Inc. – OTC:CNBX

Founder-led company

CNBX Pharmaceuticals stock price today

$0
-0.00
-94.2%
Financial Health
0
1
2
3
4
5
6
7
8
9

CNBX Pharmaceuticals stock price monthly change

-1.41%
month

CNBX Pharmaceuticals stock price quarterly change

-1.41%
quarter

CNBX Pharmaceuticals stock price yearly change

-51.05%
year

CNBX Pharmaceuticals key metrics

Market Cap
 186.17K
Enterprise value
 N/A
P/E
 -0.03
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 -0.01
PEG ratio
 N/A
EPS
 -1.39
Revenue
 N/A
EBITDA
 -694.09K
Income
 -3.69M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

CNBX Pharmaceuticals stock price history

CNBX Pharmaceuticals stock forecast

CNBX Pharmaceuticals financial statements

Profit Margin

CNBX Pharmaceuticals Inc. (OTC:CNBX): Profit margin
Feb 2023 0 -2.62M
May 2023 310.16K -173.08K -55.8%
Aug 2023 100K -573.55K -573.55%
Feb 2024 40.63K -325.45K -800.89%
CNBX income statement history

Debt to Assets

CNBX Pharmaceuticals Inc. (OTC:CNBX): Debt to assets
Feb 2023 462052 2.47M 535.35%
May 2023 662019 2.57M 388.43%
Aug 2023 499039 2.51M 504.23%
Feb 2024 163917 2.52M 1538.86%
CNBX balance sheet history

Cash Flow

CNBX Pharmaceuticals Inc. (OTC:CNBX): Cash Flow
Feb 2023 -18.53K 24.70K 19.97K
May 2023 -18.59K 0 14.99K
Aug 2023 20.51K 24.70K 65.02K
Feb 2024 -124.39K 20K 0
CNBX cash flow history

CNBX Pharmaceuticals alternative data

CNBX Pharmaceuticals
Employees

CNBX Pharmaceuticals Inc. (OTC:CNBX): Employee count
Aug 2023 5
Sep 2023 5
Oct 2023 5
Nov 2023 5
Dec 2023 5
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 2
Jul 2024 2

CNBX Pharmaceuticals other data

CNBX Pharmaceuticals
Hedge Funds Holdings Q1 2023

0.00% 0.00%
of CNBX is owned by hedge funds
1 +0
hedge funds hold CNBX stock
15 +6
shares is hold by hedge funds
CNBX hedge funds holdings changes

CNBX Pharmaceuticals
Insider Trading

CNBX Pharmaceuticals Inc. (OTC:CNBX): Insider trades (number of shares)
Period Buy Sel
Oct 2013 40000000 0
Apr 2014 0 20500000
May 2014 0 41000000
Jun 2014 0 14525000
Jul 2014 0 18239594
Transaction Date Insider Security Shares Price per share Total value Source
Sale
CANNABICS INC. 10 percent owner
 COMMON STOCK 18,239,594 N/A N/A
Sale
CANNABICS INC. 10 percent owner
 Common Stock 14,525,000 $0.01 $145,250
Sale
MILLS THOMAS E 10 percent owner
 common stock 20,500,000 $0.01 $205,000
Sale
CANNABICS INC. 10 percent owner
 Common Stock 20,500,000 $0.01 $205,000
Sale
MILLS THOMAS E 10 percent owner
 common stock 20,500,000 $0.01 $205,000
Purchase
MILLS THOMAS E 10 percent owner
 COMMON STOCK 20,000,000 $0.01 $100,000
Purchase
MILLS THOMAS E 10 percent owner
 COMMON STOCK 20,000,000 $100,000 $2,000,000,000,000
Purchase
MILLS THOMAS E 10 percent owner
 common stock 20,000,000 $0.01 $100,000
Sale
HILFORD LOU 10 percent owner
 common 2,000,000 $0 $6,000
Purchase
MILLS THOMAS E 10 percent owner
 common 2,000,000 $0 $6,000
CNBX insider trading transactions

CNBX Pharmaceuticals
Executives

Insider Compensation
Mr. Eyal Barad (1965) Co-Founder, Chief Executive Officer & Director
 $268,720
Mr. Gabriel Yariv (1976) Pres, Chief Operating Officer & Chairman
 $241,790
Dr. Eyal Ballan Ph.D. (1973) Co-Founder & Chief Technology Officer
 $225,630
Mr. Uri Ben-Or CPA, CPA, M.B.A., MBA (1970) Chief Financial Officer
 $76,400

Frequently Asked Questions (FAQ)

  • What's the price of CNBX Pharmaceuticals stock today?

    One share of CNBX Pharmaceuticals stock can currently be purchased for approximately $0.

  • When is CNBX Pharmaceuticals's next earnings date?

    Unfortunately, CNBX Pharmaceuticals's (CNBX) next earnings date is currently unknown.

  • Does CNBX Pharmaceuticals pay dividends?

    No, CNBX Pharmaceuticals does not pay dividends.

  • How much money does CNBX Pharmaceuticals make?

    CNBX Pharmaceuticals has a market capitalization of 186.17K and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 68.29% to 130.07K US dollars.

  • What is CNBX Pharmaceuticals's stock symbol?

    CNBX Pharmaceuticals Inc. is traded on the OTC under the ticker symbol "CNBX".

  • What is CNBX Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of CNBX Pharmaceuticals?

    Shares of CNBX Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are CNBX Pharmaceuticals's key executives?

    CNBX Pharmaceuticals's management team includes the following people:

    • Mr. Eyal Barad Co-Founder, Chief Executive Officer & Director(age: 60, pay: $268,720)
    • Mr. Gabriel Yariv Pres, Chief Operating Officer & Chairman(age: 49, pay: $241,790)
    • Dr. Eyal Ballan Ph.D. Co-Founder & Chief Technology Officer(age: 52, pay: $225,630)
    • Mr. Uri Ben-Or CPA, CPA, M.B.A., MBA Chief Financial Officer(age: 55, pay: $76,400)

  • Is CNBX Pharmaceuticals founder-led company?

    Yes, CNBX Pharmaceuticals is a company led by its founders Mr. Eyal Barad and Dr. Eyal Ballan Ph.D..

  • How many employees does CNBX Pharmaceuticals have?

    As Jul 2024, CNBX Pharmaceuticals employs 2 workers.

  • When CNBX Pharmaceuticals went public?

    CNBX Pharmaceuticals Inc. is publicly traded company for more then 12 years since IPO on 17 May 2013.

  • What is CNBX Pharmaceuticals's official website?

    The official website for CNBX Pharmaceuticals is cnbxpharma.com.

  • Where are CNBX Pharmaceuticals's headquarters?

    CNBX Pharmaceuticals is headquartered at #3 Bethesda Metro Center, Bethesda, MD.

  • How can i contact CNBX Pharmaceuticals?

    CNBX Pharmaceuticals's mailing address is #3 Bethesda Metro Center, Bethesda, MD and company can be reached via phone at 877 424 2429.

CNBX Pharmaceuticals company profile:

CNBX Pharmaceuticals Inc.

cnbxpharma.com
Exchange:

OTC

Full time employees:

5

Industry:

Biotechnology

Sector:

Healthcare

CNBX Pharmaceuticals Inc., a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it is developing RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.

877 424 2429
#3 Bethesda Metro Center
Bethesda, MD 20814

CIK: 0001343009
ISIN: US13764M1009
CUSIP: 13764M100